40 related articles for article (PubMed ID: 6365015)
1. Carbamazepine and haloperidol v placebo and haloperidol in excited psychoses. A controlled study.
Klein E; Bental E; Lerer B; Belmaker RH
Arch Gen Psychiatry; 1984 Feb; 41(2):165-70. PubMed ID: 6365015
[TBL] [Abstract][Full Text] [Related]
2. Lithium treatment of Bipolar disorder in adults: A systematic review of randomized trials and meta-analyses.
Fountoulakis KN; Tohen M; Zarate CA
Eur Neuropsychopharmacol; 2022 Jan; 54():100-115. PubMed ID: 34980362
[TBL] [Abstract][Full Text] [Related]
3. Oxcarbazepine for Behavioral Disorders after Brain Injury: Factors Influencing Efficacy.
Pozzi M; Avantaggiato P; Pastore V; Carnovale C; Clementi E; Strazzer S
Brain Sci; 2021 Jul; 11(7):. PubMed ID: 34356183
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of Carbamazepine and Its Derivatives in the Treatment of Bipolar Disorder.
Grunze A; Amann BL; Grunze H
Medicina (Kaunas); 2021 Apr; 57(5):. PubMed ID: 33946323
[No Abstract] [Full Text] [Related]
5. A phase 2a randomised, double-blind, placebo-controlled, parallel-group, add-on clinical trial of ebselen (SPI-1005) as a novel treatment for mania or hypomania.
Sharpley AL; Williams C; Holder AA; Godlewska BR; Singh N; Shanyinde M; MacDonald O; Cowen PJ
Psychopharmacology (Berl); 2020 Dec; 237(12):3773-3782. PubMed ID: 32909076
[TBL] [Abstract][Full Text] [Related]
6. The Black Book of Psychotropic Dosing and Monitoring.
Schatzberg AF; Charles D
Psychopharmacol Bull; 2018 Jan; 48(1):64-153. PubMed ID: 29382960
[No Abstract] [Full Text] [Related]
7. The International College of Neuro-Psychopharmacology (CINP) Treatment Guidelines for Bipolar Disorder in Adults (CINP-BD-2017), Part 2: Review, Grading of the Evidence, and a Precise Algorithm.
Fountoulakis KN; Yatham L; Grunze H; Vieta E; Young A; Blier P; Kasper S; Moeller HJ
Int J Neuropsychopharmacol; 2017 Feb; 20(2):121-179. PubMed ID: 27816941
[TBL] [Abstract][Full Text] [Related]
8. Carbamazepine for schizophrenia.
Leucht S; Helfer B; Dold M; Kissling W; McGrath J
Cochrane Database Syst Rev; 2014 May; 2014(5):CD001258. PubMed ID: 24789267
[TBL] [Abstract][Full Text] [Related]
9. Combination therapy for manic phases: a critical review of a common practice.
Geoffroy PA; Etain B; Henry C; Bellivier F
CNS Neurosci Ther; 2012 Dec; 18(12):957-64. PubMed ID: 23095277
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of pharmacotherapy in bipolar disorder: a report by the WPA section on pharmacopsychiatry.
Fountoulakis KN; Kasper S; Andreassen O; Blier P; Okasha A; Severus E; Versiani M; Tandon R; Möller HJ; Vieta E
Eur Arch Psychiatry Clin Neurosci; 2012 Jun; 262 Suppl 1():1-48. PubMed ID: 22622948
[TBL] [Abstract][Full Text] [Related]
11. Refractoriness in bipolar disorder: definitions and evidence-based treatment.
Fountoulakis KN
CNS Neurosci Ther; 2012 Mar; 18(3):227-37. PubMed ID: 22070611
[TBL] [Abstract][Full Text] [Related]
12. Anticonvulsant drugs in bipolar disorder.
Grunze H; Schlösser S; Amann B; Walden J
Dialogues Clin Neurosci; 1999 Jun; 1(1):24-40. PubMed ID: 22033602
[TBL] [Abstract][Full Text] [Related]
13. Class effect of pharmacotherapy in bipolar disorder: fact or misbelief?
Fountoulakis KN; Gonda X; Vieta E; Rihmer Z
Ann Gen Psychiatry; 2011 Mar; 10(1):8. PubMed ID: 21435226
[TBL] [Abstract][Full Text] [Related]
14. Antiepileptics for aggression and associated impulsivity.
Huband N; Ferriter M; Nathan R; Jones H
Cochrane Database Syst Rev; 2010 Feb; 2010(2):CD003499. PubMed ID: 20166067
[TBL] [Abstract][Full Text] [Related]
15. Thirty years of clinical experience with carbamazepine in the treatment of bipolar illness: principles and practice.
Post RM; Ketter TA; Uhde T; Ballenger JC
CNS Drugs; 2007; 21(1):47-71. PubMed ID: 17190529
[TBL] [Abstract][Full Text] [Related]
16. NMDA receptor antagonist effects, cortical glutamatergic function, and schizophrenia: toward a paradigm shift in medication development.
Krystal JH; D'Souza DC; Mathalon D; Perry E; Belger A; Hoffman R
Psychopharmacology (Berl); 2003 Sep; 169(3-4):215-33. PubMed ID: 12955285
[TBL] [Abstract][Full Text] [Related]
17. Metabolism, pharmacogenetics, and metabolic drug-drug interactions of antipsychotic drugs.
Fang J; Gorrod JW
Cell Mol Neurobiol; 1999 Aug; 19(4):491-510. PubMed ID: 10379422
[TBL] [Abstract][Full Text] [Related]
18. Treatment approaches for acute mania.
Chou JC; Tuma I; Sweeney EA
Psychiatr Q; 1993; 64(4):331-44. PubMed ID: 7901859
[TBL] [Abstract][Full Text] [Related]
19. Clinical pharmacokinetics and pharmacological effects of carbamazepine and carbamazepine-10,11-epoxide. An update.
Bertilsson L; Tomson T
Clin Pharmacokinet; 1986; 11(3):177-98. PubMed ID: 3524954
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
